Progress in the battle against
HIV/AIDS only happens through years of painstaking research and
experimentation. HIV Cure Foundation matches philanthropic contributions to
fund the innovations that continue to build on decades of progress towards
ending the HIV/AIDS epidemic. Just as yesterday’s clinical trials directly impact people currently living with HIV/AIDS, today’s hard work will one day make
HIV/AIDS an historical relic. HIV Cure Foundation is there to ensure the
HIV Cure Foundation (HCF) was founded by a group of passionate individuals determined to find a cure for the disease that had plagued the world since 1981. HCF was created for the individuals who need #theHIVCure more than anything. HCF filed for a 501(c)3 determination from the IRS on November 2, 2020.
Moving the needle requires identifying and funding innovative, science-based research. HIV Cure Foundation is committed to providing the funds for clinical research that will cure an individual from taking antiretroviral drugs the rest of their life.
As of March 2021, HIV Cure Foundation announced the support of a Phase 1 study to evaluate the safety of T-cell gene therapy in participants with HIV that is well-controlled on antiretroviral therapy. This research is one of many crucial avenues of experimentation in the ongoing fight against HIV/AIDS. Should this research prove effective, it would cure the individual from the necessity of taking a daily pill the rest of their life and be free of side effects.
Maryland-based, American Gene Technologies is a clinical-stage gene and cell therapy company that has developed AGT103-T, a single dose, autologous cell therapy intended to cure HIV.
Greenlighted by the FDA, human clinical trials are currently underway in Washington, DC at Georgetown University and Washington Health Institute. This study is registered with The NIH National Library of Medicine Clinical Trials Registry.
this study works
does this trial mean for an individual infected with HIV?
HIV Cure Foundation is currently reviewing several promising research trials; the American Gene project is our first to receive a funding grant. Their Phase 1 human clinical trial just began and will cost upwards of $2.7 million. The treatment fees associated with a single infected patient are $150,000 each. This will possibly cure one patient by extracting, genetically modifying and reinfusing their HIV-specific cells! As more patients are introduced into the study, the cost will decrease incrementally per participant. Your gift today can help us move the needle for a potential cure.
Your donation in any amount will help
make life-changing research possible.
#theHIVCure is on the horizon, we invite you to give generously today:
• any portion of one patient’s clinical trial ($500...$2,500...$25,000...any amount)
• an entire patient ($150,000)
• an entire trial! ($1mil+)